AVITA MEDICAL INC COM Overview
ATTO market data
Business OverviewA provider-written description of this company or fund, with its source and observation date.
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.
- Source
- massive
- Observed
- Cadence
- Reference data reviewed periodically
- Status
- fresh
Price HistoryDaily closing prices from recorded market data. The latest point represents the most recent completed daily period; prices can move before the next point appears.
ATTO price chart · 1M
- O
- 15.00
- H
- 15.32
- L
- 15.00
- C
- 15.32
- Vol
- 1,068.00
Daily history from Jan 4, 2016
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & PerformanceOpen, range, return and notional-volume facts calculated from daily market bars.
- Open
- $15.00
- Previous Close
- $15.02
- Day High
- $15.32
- Day Low
- $15.00
- 52 Week High
- $27.99
- 52 Week Low
- $13.01
- 7 Day Return
- +0.56%
- 30 Day Return
- -6.33%
- 90 Day Return
- -22.59%
- 1 Year Return
- —
- Daily Notional Volume
- $16.4K Latest daily bar volume multiplied by its closing price.
Valuation & ProfitabilityProvider-backed valuation, profitability, and range metrics for the selected company. Display-only; never feeds scores or decisions.
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.41 Diluted earnings per share over the trailing twelve months.
- Beta
- 16,303.92 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -4,490.9% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $12.94 – $28.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $712.2M.
Company NewsRecent source-attributed headlines linked to this symbol. Repeated headlines and low-signal items are filtered. Open a headline for its source and context.
10 captured
Attovia Therapeutics Announces Positive Topline 12-Week Results from Phase 1b Study of ATTO-1310Fiscal.ai ·
Quanex Building Products, Concrete Pumping, SanDisk And Other Big Stocks Moving Higher On FridayBenzinga ·